KOSDAQ - Delayed Quote KRW

curacle co.,ltd. (365270.KQ)

6,420.00
-170.00
(-2.58%)
As of 1:50:38 PM GMT+9. Market Open.
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,632,550.30
1,632,550.30
10,294,390.76
3,582,858.97
6,254,952.50
Gross Profit
1,632,550.30
1,632,550.30
10,294,390.76
3,582,858.97
6,254,952.50
Operating Expense
14,267,238
14,267,238
20,802,501
15,565,070
13,124,548
Operating Income
-12,634,687.70
-12,634,687.70
-10,508,110.24
-11,982,211.03
-6,869,595.50
Net Non Operating Interest Income Expense
-1,304,782.09
-1,304,782.09
-439,609.06
237,837.14
219,558.17
Pretax Income
-14,886,473.15
-14,886,473.15
-11,585,769.15
-11,405,592.52
-6,677,788.86
Net Income Common Stockholders
-14,886,473.15
-14,886,473.15
-11,585,769.15
-11,405,592.52
-6,677,788.86
Basic EPS
-1.07k
--
-836.00
-829.00
-542.00
Diluted EPS
-1.07k
--
-836.00
-829.00
-542.00
Basic Average Shares
13,860.78
--
13,858.58
13,758.25
12,331.62
Diluted Average Shares
13,860.78
--
13,858.58
13,758.25
12,331.62
Total Operating Income as Reported
-12,634,687.98
-12,634,687.98
-10,508,110.22
-11,982,211.45
-6,869,595.18
Rent Expense Supplemental
12,361
12,361
12,313
10,411
3,426
Total Expenses
14,267,238
14,267,238
20,802,501
15,565,070
13,124,548
Net Income from Continuing & Discontinued Operation
-14,886,473.15
-14,886,473.15
-11,585,769.15
-11,405,592.52
-6,677,788.86
Normalized Income
-13,051,395.15
-13,051,395.15
-10,910,472.15
-11,406,816.52
-6,564,000.86
Interest Income
1,149,893
1,149,893
907,873
537,732
216,746
Interest Expense
2,454,675
2,454,675
1,347,482
299,895
22,044
Net Interest Income
-1,304,782.09
-1,304,782.09
-439,609.06
237,837.14
219,558.17
EBIT
-12,431,798.15
-12,431,798.15
-10,238,287.15
-11,105,697.52
-6,655,744.86
EBITDA
-11,764,565.15
-11,764,565.15
-9,594,932.15
-10,603,044.52
-6,273,501.86
Reconciled Depreciation
667,233
667,233
643,355
502,653
382,243
Net Income from Continuing Operation Net Minority Interest
-14,886,473.15
-14,886,473.15
-11,585,769.15
-11,405,592.52
-6,677,788.86
Total Unusual Items Excluding Goodwill
-1,835,078
-1,835,078
-675,297
1,224
-113,788
Total Unusual Items
-1,835,078
-1,835,078
-675,297
1,224
-113,788
Normalized EBITDA
-9,929,487.15
-9,929,487.15
-8,919,635.15
-10,604,268.52
-6,159,713.86
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

378800.KQ Shaperon Inc.
2,825.00
-1.91%
 
358570.KQ GI Innovation, Inc.
14,060.00
-6.02%
 
141080.KQ LigaChem Biosciences Inc.
97,600.00
-1.31%
 
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
 
CNTA Centessa Pharmaceuticals plc
12.30
-0.73%
 
CDTX Cidara Therapeutics, Inc.
18.63
-2.72%
 
NAMS NewAmsterdam Pharma Company N.V.
18.37
-4.67%
 
MIRM Mirum Pharmaceuticals, Inc.
44.27
-2.14%
 
SGMT Sagimet Biosciences Inc.
3.2600
+1.87%
 
DAWN Day One Biopharmaceuticals, Inc.
6.45
-4.59%